Vontobel Holding
IOVA icon

Vontobel Holding’s Iovance Biotherapeutics IOVA Stock Holding History

Vontobel Holding’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,067
Closed -$26.2K – 1479
2025
Q3 		$26.2K Buy
+12,067
New +$28.5K ﹤0.01% 1340
2025
Q1 		– Sell
-19,375
Closed -$143K – 1124
2024
Q4 		$143K Buy
19,375
+435
+2% +$4.03K ﹤0.01% 1033
2024
Q3 		$178K Buy
18,940
+4,647
+33% +$44K ﹤0.01% 1016
2024
Q2 		$115K Buy
+14,293
New +$153K ﹤0.01% 1020
2023
Q4 		– Sell
-139,014
Closed -$633K – 1135
2023
Q3 		$633K Sell
139,014
-3,284
-2% -$21.4K 0.01% 699
2023
Q2 		$1M Buy
+142,298
New +$1.02M 0.01% 596

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $2.28B AUM 7.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return